Robert W. Baird analyst Vikram Kesavabhotla maintained a Buy rating on R1 RCM (NASDAQ:RCM) on Friday, setting a price target of $27, which is approximately 24.83% above the present share price of $21.63.
Kesavabhotla expects R1 RCM to post earnings per share (EPS) of $0.07 for the third quarter of 2021.
The current consensus among 4 TipRanks analysts is for a Strong Buy rating of shares in R1 RCM, with an average price target of $31.
The analysts price targets range from a high of $35 to a low of $27.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $353.4 million and a net profit of $37.4 million. The company's market cap is $6.03 billion.
According to TipRanks.com, Robert W. Baird analyst Vikram Kesavabhotla is currently ranked with 1 stars on a 0-5 stars ranking scale, with an average return of -0.9% and a 43.33% success rate.
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.